pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['key,note,62', 'keynote,671', 'keynote 671', 'cisplatin', 'pembro', 'lcsm,(-blcsm)']
keynote 671: pts with stage ii-iiib (ajcc v8) randomized to neoadj cisplatin-doublet +/- pembro followed by pembro/plcb efs (hr 0.58) 2 yr ~ 62% vs. 40.6% pcr 18% vs 4% early separation of os curve #asco23 #lcsm 
Assistant Prof | Thoracic Oncology & Phase-I @karmanoscancer | EIC @BTFCancerNews | Previously @MayoCancerCare @gundersenhealth @JeffHealthAb | Tweets my own